Literature DB >> 6751875

Inhibition of DNA replication in vitro by pefloxacin.

B Badet, P Hughes, M Kohiyama, P Forterre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6751875     DOI： 10.1016/0014-5793(82)80199-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  4 in total

1.  Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid.

Authors:  N Moniot-Ville; J Guibert; N Moreau; J F Acar; E Collatz; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

Review 2.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 3.  Pefloxacin clinical pharmacokinetics.

Authors:  F Bressolle; F Gonçalves; A Gouby; M Galtier
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

4.  High positive supercoiling in vitro catalyzed by an ATP and polyethylene glycol-stimulated topoisomerase from Sulfolobus acidocaldarius.

Authors:  P Forterre; G Mirambeau; C Jaxel; M Nadal; M Duguet
Journal:  EMBO J       Date:  1985-08       Impact factor: 11.598
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.